Chi Meng
Impact in
- Toxicology top 10%
- Organic Chemistry top 10%
- Synthesis and biological activity
Papers in
-
- Nanoplatforms for cancer theranostics 12
-
- Bioactive Compounds and Antitumor Agents 3
- Co-authors
- Yong Ling (22 shared papers)Jianqiang Qian (17 shared papers)Zhongyuan Xu (12 shared papers)Fude Feng (3 shared papers)Peng Wei Zhu (9 shared papers)Chang‐Chun Ling (8 shared papers)Weizhong Zhu (5 shared papers)Fansheng Ran (5 shared papers)
In The Last Decade
Chi Meng
25 papers receiving 618 citations
Chi Meng's Hit Papers
Peers
Comparison fields: 5 of 65
- Toxicology 25
- Organic Chemistry 132
- Pharmacology 38
- Pulmonary and Respiratory Medicine 112
- Biomedical Engineering 124
Countries citing papers authored by Chi Meng
This map shows the geographic impact of Chi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Meng more than expected).
Fields of papers citing papers by Chi Meng
This network shows the impact of papers produced by Chi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Meng. The network helps show where Chi Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies Hit paper breakdown → | 2024 | 89 |
| 2 | 2019 | 54 | |
| 3 | 2021 | 53 | |
| 4 | 2020 | 43 | |
| 5 | 2019 | 40 | |
| 6 | 2019 | 38 | |
| 7 | 2020 | 35 | |
| 8 | 2021 | 28 | |
| 9 | 2020 | 27 | |
| 10 | 2020 | 27 | |
| 11 | 2022 | 23 | |
| 12 | 2021 | 22 | |
| 13 | 2023 | 21 | |
| 14 | 2022 | 17 | |
| 15 | 2021 | 16 | |
| 16 | 2022 | 15 | |
| 17 | 2020 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2021 | 10 | |
| 20 | 2022 | 10 |
About Chi Meng
Chi Meng is a scholar working on Biomedical Engineering, Toxicology, Organic Chemistry, Spectroscopy and Molecular Biology, having authored 26 papers that have together received 627 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Synthesis and biological activity (6 papers), Redox biology and oxidative stress (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Luminescence and Fluorescent Materials (3 papers), Molecular Sensors and Ion Detection (3 papers) and Piperaceae Chemical and Biological Studies (2 papers). The work is most often cited by research in Toxicology (25 citations), Organic Chemistry (132 citations), Pharmacology (38 citations), Pulmonary and Respiratory Medicine (112 citations) and Biomedical Engineering (124 citations). Chi Meng has collaborated with scholars based in China, Macao and Taiwan. Frequent co-authors include Yong Ling, Jianqiang Qian, Zhongyuan Xu, Fude Feng, Peng Wei Zhu, Chang‐Chun Ling, Weizhong Zhu, Fansheng Ran, Weijie Gao and Hong Dai. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Natural Products, Molecules, Journal of Medicinal Chemistry and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.